Lupin is comprised of a fast growing, innovative and robust team of manufacturing, Research and Development and commercial divisions. Together these entities make up the generic and branded U.S. business. Lupin has a significant generic pipeline, and a branded focus on women’s health. Our first Research and Development facility in the US is located in Coral Springs, Florida which focuses on generic and branded orally inhaled and nasal drug products. Somerset, New Jersey is home to one of Fifteen commercial manufacturing sites globally and the only commercial manufacturing facility in the United States for Lupin, as well as additional Research and Development teams. Lupin is prided on being people-focused and centered around how impactful we are with our customers. Dollars are not a measure of success but rather the people we help along the way.
Lupin vision was to grow a specialty brand business that launches innovative new products to address unmet medical needs.
Since its founding, Lupin’s U.S. brand business has been driven by that vision. We have marketed a range of products across therapeutic categories, including ANTARA® (fenofibrate) and METHERGINE® (methylergonovine maleate), as well as launching Inspira Chamber® (valved holding chamber), Brovana Inhalation Solution and Xopenex HFA. While these brands treat a wide range of medical conditions, they have one important commonality: they are part of a sincere effort to broaden the treatment landscape for the benefit of patients and providers alike.
Our search for cutting-edge medicines to improve the treatment of special conditions and populations is never over. We are building our specialty business in therapeutic areas where we have synergy, including respiratory and neurological diseases.
The Role
Lupin is looking for an experienced and passionate leader to be a part of our Global Regulatory Affairs (GRA) organization. In this role, you will be primarily responsible for the development of US/Global regulatory strategies to advance Lupin’s portfolio of development pipeline candidate drugs. You will provide strategic input and ensure operational execution of global and US submission activities. You will be responsible for interfacing directly with the US FDA as the primary contact for the company for assigned programs.
This position is based in our Somerset, NJ office which requires onsite presence 50% of the time per our hybrid policy. This position will report to the SVP, RA (Generics, Biosimilar and Specialty).
Responsibilities:
The key responsibilities of this role will include, but are not limited to:
Requirements:
Lupin is an equal opportunity and affirmative action employer. All qualified applicants will receive consideration for employment without regard to race, color, national origin, gender, religion, age, disability, veteran’s status, or any other classification as required by applicable law.
Physical Requirements
The physical requirements of the position generally include: standing, walking, sitting, using hands and fingers, reaching with hands and arms, talking and hearing. In some circumstances, bending, kneeling, crouching, stooping, and crawling may apply. This position may require lifting up to 15 pounds occasionally. Generally work is performed in an office environment.
Search Firm Representatives Please Read Carefully
Lupin USA, and its Affiliates does not accept unsolicited assistance from search firms for employment opportunities. All CVs / resumes submitted by search firms for any current openings at our company without a valid written search agreement in place will be deemed the sole property of Lupin. No fee will be paid in the event a candidate is hired by Lupin as a result of an agency referral where no pre-existing agreement is in place. Where agency agreements are in place, introductions are position specific. Please, No phone calls or emails
Software Powered by iCIMS
www.icims.com